Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2003
05/21/2003CN1418679A Medicine compositions for treating hepatitis, and its prepn. method
05/21/2003CN1418675A Medicine extracted for natural plant used speically for treating AIDS
05/21/2003CN1418673A Method for extracting coxtex mouten total glucoside for treating hepatitis
05/21/2003CN1418666A Chinese patent drug for treating hepatitis
05/21/2003CN1418664A Lireqing injecta (for clearing heat and diminishing inflammation)
05/21/2003CN1418661A Traditional Chinese medicine prepn. for treating Hepatitis
05/21/2003CN1418648A Medicine for treating hepatitis
05/21/2003CN1418643A Method for bathing with traditional Chinese medicine for anti human immunodeficiency virus and improving immunity
05/21/2003CN1418638A Ribavirin oral disintegrant for treating virus influenza, and its prepn. method
05/21/2003CN1418637A Silicibinin-N-methylglucamine disperser for treating hepatitis, and its prepn. method
05/21/2003CN1418636A Compound prepn. contg. sophocarpidine and phosphatide, and its prepn. method
05/21/2003CN1418635A Aspirin oral disintegrant used for treating influenza and fever, and its prepn. method
05/21/2003CN1418634A Prednisolone oral disintegrant for treating acute bacterial infection, and its prepn. method
05/21/2003CN1418632A Compound prepn. contg. ceftazidime and tazobactam for injection use
05/21/2003CN1418565A Application method for silkworm medicine (together with folium mori)
05/21/2003CN1109108C Method for resolution of a racemic mixture of nucleoside enantioners
05/21/2003CN1109046C Induction of cytotoxic T-lymphocyte responses
05/21/2003CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1108967C Metering valve
05/21/2003CN1108821C Preparation of multiepitope-epitope vaccine
05/21/2003CN1108820C Preparation of epitope vaccine with single monoepitope or multiple monoepitope duplication
05/21/2003CN1108819C Preparation of dissociation-resisting epitope vaccine
05/21/2003CN1108813C Detoxicating stasis-dispersing inflammation-relieving antalgic and refreshing medicine and its preparing process
05/21/2003CN1108806C Ningxueling capsule
05/21/2003CA2474159A1 Method for determining sensitivity to a bacteriophage
05/20/2003US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566506 Useful in extending the in vivo circulating life of biologically active materials
05/20/2003US6566498 Proteins for use in the treatment of thrombosis and tumor metastisis
05/20/2003US6566491 Cyclopeptide derivatives
05/20/2003US6566401 Treating or preventing drug toxicity using a toxicity reducing amount of N-acetylcysteine
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566363 5-amino-3-substituted-pyrazolo(4,5-d)thiazole compounds that mediate and/or inhibit the activity of cyclin-dependent kinases, useful for treating cancer, angiogenesis and cellular proliferation
05/20/2003US6566362 Use as topical antibiotics
05/20/2003US6566357 Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
05/20/2003US6566355 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens
05/20/2003US6566354 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
05/20/2003US6566350 Minocycline-containing compositions
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566117 Immortal cell line derived from grouper Epinephelus coioides and its applications therein
05/20/2003US6566095 Blocking transmission of viral particles to animals; obtain animal, administer antibody, incubate with viral sample, monitor viral infection, reduction in viral infection indicates antagonist
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6566048 Acetyl-COA-carboxylase from Candida albicans
05/20/2003US6565897 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
05/20/2003US6565890 Inorganic reaction product containing tungsten and vanadium oxide
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565854 Killing microorganisms, especially human pathogens; use in would dressings; animal feeds; vaccines
05/20/2003US6565831 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/20/2003CA2289219C 1-substituted, 2-substituted 1h-imidazo[4,5-c]quinolin-4-amines
05/20/2003CA2281244C Process for preparing trovafloxacin acid salts
05/20/2003CA2223579C Novel recombinant temperature sensitive mutants of influenza
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2131551C Conjugates formed from heat shock proteins and oligo- or polysaccharides
05/15/2003WO2003040726A2 Screening for hepatitis c virus entry inhibitors
05/15/2003WO2003040684A2 Screening for antiviral affecting signal peptidase
05/15/2003WO2003040399A2 Therapeutic methods for nucleic acid delivery vehicles
05/15/2003WO2003040384A1 Recombinant antibodies for the detection and neutralization of anthrax toxin
05/15/2003WO2003040375A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040369A2 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines
05/15/2003WO2003040366A2 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003WO2003040358A1 Somatic cell derived embryonic stem cells and its differentiated cells
05/15/2003WO2003040351A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate
05/15/2003WO2003040333A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040188A1 Antibody stimulating il-1ra production
05/15/2003WO2003040187A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
05/15/2003WO2003040179A1 High level constitutive production of anthrax protective antigen
05/15/2003WO2003040178A1 Method for identifying or screening anti-viral agents
05/15/2003WO2003040148A1 A process for the preparation of cefixime via alkyl-or aryl-sulfonates
05/15/2003WO2003040146A1 Novel carbapenem compounds
05/15/2003WO2003040145A1 Anhydrous crystal form of valaciclovir hydrochloride
05/15/2003WO2003040138A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040137A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040136A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040135A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040131A1 Aminopyrimidines and pyridines
05/15/2003WO2003040118A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003WO2003040117A1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040112A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/15/2003WO2003040104A1 Dimeric pharmaceutical compounds and their use
05/15/2003WO2003040099A1 Preparation of benzosuberonylpiperidine compounds
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003040084A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2003039559A1 Pharmaceutical combinatons comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
05/15/2003WO2003039549A2 Selective antibacterial agents
05/15/2003WO2003039548A1 Hydrazono-malonitriles
05/15/2003WO2003039546A1 New uses for anti-malarial therapeutic agents
05/15/2003WO2003039533A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
05/15/2003WO2003039529A1 Selective antibacterial agents
05/15/2003WO2003039528A1 Pharmaceutical composition comprising an adenosine a1/a2 agonist and a sodium hydrogen exchanger inhibitor
05/15/2003WO2003039523A2 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
05/15/2003WO2003039520A1 Orodispersible tablet having high homogeneity and the preparation method thereof
05/15/2003WO2003039517A1 Process for preparing quick dissolving, high loading ribavirin compositions
05/15/2003WO2003039510A1 Compositions containing oils having a specific gravity higher than the specific gravity of water
05/15/2003WO2003039472A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003WO2003039450A2 Improvements in or relating to inhibition of viruses
1 ... 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 ... 1798